市場調査レポート
商品コード
1387146
ポリクローナル抗体市場レポート:2030年までの動向、予測、競合分析Polyclonal Antibodie Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ポリクローナル抗体市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月27日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
ポリクローナル抗体の動向と予測
世界のポリクローナル抗体市場は、2024年から2030年までのCAGRが7.8%で、2030年までに推定68億米ドルに達すると予想されます。この市場の主な促進要因は、がん患者や感染症の増加、バイオ医薬品事業における研究開発努力の増加、抗体医薬の技術開発の進展などです。世界のポリクローナル抗体市場の将来は、学術研究センター、製薬およびバイオテクノロジー企業、診断センター、病院市場でのビジネスチャンスで有望視されています。
ポリクローナル抗体市場洞察
Lucintelの予測では、ポリクローナル抗体の製造は安価であり、多くの生物種が存在することから、診断薬は予測期間中に最も高い成長が見込まれます。
医薬品、診断アッセイ、研究ツールなど、さまざまな目的でポリクローナル抗体を使用する製薬およびバイオテクノロジー企業が増加しているため、この市場の中では製薬・バイオテクノロジー企業が最大セグメントであり続けると予想されます。
北米は、バイオテクノロジーや医薬品産業における研究開発への資金が増加していること、また同地域の病院、クリニック、研究所で構成される医療システムが確立されていることから、予測期間中も最大地域であり続けるでしょう。
Polyclonal Antibodie Trends and Forecast
The future of the global polyclonal antibodie market looks promising with opportunities in the academic & research center, pharmaceutical & biotechnology company, diagnostic center, and hospital markets. The global polyclonal antibodie market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are rising cancer cases and infectious diseases, increasing R&D efforts in the biopharmaceutical business, and as well as the increasing technological developments in antibody-based medications.
A more than 150-page report is developed to help in your business decisions.
Polyclonal Antibodie by Segment
The study includes a forecast for the global polyclonal antibodie by product, source, application, end use, and region.
Polyclonal Antibodie Market by Product [Shipment Analysis by Value from 2018 to 2030]:
Polyclonal Antibodie Market by Source [Shipment Analysis by Value from 2018 to 2030]:
Polyclonal Antibodie Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Polyclonal Antibodie Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Polyclonal Antibodie Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Polyclonal Antibodie Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies polyclonal antibodie companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the polyclonal antibodie companies profiled in this report include-
Polyclonal Antibodie Market Insights
Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period as polyclonal antibody manufacturing is inexpensive to produce and the presence of numerous species in it.
Within this market, pharmaceutical and biotechnology companies is expected to remain the largest segment due to he increasing use ofpolyclonal antibodies by the pharmaceutical and biotechnology industries for a range of purposes, including medicines, diagnostic assays, and research tools.
North America will remain the largest region during the forecast period due to the growing funding for research and development in the biotechnology and pharamceutical industries and well-established healthcare system that comprises hospitals, clinics, and laboratories in the region.
Features of the Global Polyclonal Antibodie Market
Market Size Estimates: Polyclonal antibodie market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Polyclonal antibodie market size by various segments, such as by product, source, application, end use, and region in terms of value ($B).
Regional Analysis: Polyclonal antibodie market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products sources, applications, end uses, and regions for the polyclonal antibodie market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the polyclonal antibodie market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the polyclonal antibodie market size?
Answer: The global polyclonal antibodie market is expected to reach an estimated $6.8 billion by 2030.
Q2. What is the growth forecast for polyclonal antibodie market?
Answer: The global polyclonal antibodie market is expected to grow with a CAGR of 7.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the polyclonal antibodie market?
Answer: The major drivers for this market are rising cancer cases and infectious diseases, increasing R&D efforts in the biopharmaceutical business, and as well as the increasing technological developments in antibody-based medications.
Q4. What are the major segments for polyclonal antibodie market?
Answer: The future of the polyclonal antibodie market looks promising with opportunities in the academic & research center, pharmaceutical & biotechnology company, diagnostic center, and hospital markets.
Q5. Who are the key polyclonal antibodie market companies?
Answer: Some of the key polyclonal antibodie companies are as follows:
Q6. Which polyclonal antibodie market segment will be the largest in future?
Answer: Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period as polyclonal antibody manufacturing is inexpensive to produce and the presence of numerous species in it.
Q7. In polyclonal antibodie market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region during the forecast period due to the growing funding for research and development in the biotechnology and pharamceutical industries and well-established healthcare system that comprises hospitals, clinics, and laboratories in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.